FibroGen, Inc revenue for the last year amounted to 147.75 M USD, the most of which — 147.75 M USD — came from its highest performing source at the moment, Novel Therapeutics, the year earlier bringing 140.73 M USD. The greatest contribution to the revenue figure was made by China — last year it brought FibroGen, Inc 109.38 M USD, and the year before that — 84.63 M USD.